您的位置: 首页 > 农业专利 > 详情页

BŪDAI IR KOMPOZICIJOS, SKIRTI ORGANŲ IŠEMINĖS REPERFUZIJOS PAŽEIDIMO PREVENCIJAI
专利权人:
Inc.;Quark Pharmaceuticals
发明人:
SQUIERS, Elizabeth C.,ERLICH, Shai,ROTHENSTEIN, Daniel,SHARON, Nir,ODENHEIMER, Daniel J.,FEINSTEIN, Elena
申请号:
LT15729289
公开号:
LT3149172T
申请日:
2015.05.27
申请国别(地区):
LT
年份:
2018
代理人:
摘要:
The invention, in some embodiments, relates to compounds and methods for the prevention of ischemia reperfusion injury (IRI) in organs, and in particular to IRI in organs aged 35 years and older. Specific uses include prevention of IRI in native organs in vivo, in reimplantations and in transplantations of donor organs aged 35 years and older. Additional embodiments include the prophylaxis of delayed graft function (DGF) and reduction in the frequency, amount and duration of dialysis in recipients of deceased donor kidney transplantations. The methods entail contacting the organ in vivo or ex vivo with a temporary p53 inhibitor. Novel temporary dsNA p53 inhibitors are further provided.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充